» Articles » PMID: 6424649

Carbonic Anhydrase in Human Platelets

Overview
Journal Biochem J
Specialty Biochemistry
Date 1984 Feb 1
PMID 6424649
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The carbonic anhydrase activity of human platelets was investigated by measuring the kinetics of CO2 hydration in supernatants of platelet lysates by using a pH stopped-flow apparatus. An average carbonic anhydrase concentration of 2.1 microM was determined for pellets of human platelets. Analysis of the kinetic properties of this carbonic anhydrase yielded a Km value of 1.0 mM, a catalytic-centre activity kcat. of 130000 s-1 and an inhibition constant Ki towards ethoxzolamide of 0.3 nM. From these values, CO2 hydration inside platelets is estimated to be accelerated by a factor of 2500. When platelet lysates were subjected to affinity chromatography, only the high-activity carbonic anhydrase II could be eluted from the affinity column, whereas the carbonic anhydrase isoenzyme I, which is known to occur in high concentrations in human erythrocytes, appeared to be absent.

Citing Articles

New Insights into Conformationally Restricted Carbonic Anhydrase Inhibitors.

Combs J, Bozdag M, Cravey L, Kota A, McKenna R, Angeli A Molecules. 2023; 28(2).

PMID: 36677947 PMC: 9861757. DOI: 10.3390/molecules28020890.


The Human Carbonic Anhydrase II in Platelets: An Underestimated Field of Its Activity.

Jakubowski M, Szahidewicz-Krupska E, Doroszko A Biomed Res Int. 2018; 2018:4548353.

PMID: 30050931 PMC: 6046183. DOI: 10.1155/2018/4548353.


Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance.

Jakubowski M, Debski J, Szahidewicz-Krupska E, Turek-Jakubowska A, Gawrys J, Gawrys K Oxid Med Cell Longev. 2017; 2017:3132063.

PMID: 29090039 PMC: 5635279. DOI: 10.1155/2017/3132063.


New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.

Swenson E Curr Hypertens Rep. 2014; 16(9):467.

PMID: 25079851 DOI: 10.1007/s11906-014-0467-3.


Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy.

Alvarez B, Johnson D, Sowah D, Soliman D, Light P, Xia Y J Physiol. 2006; 579(Pt 1):127-45.

PMID: 17124262 PMC: 2075384. DOI: 10.1113/jphysiol.2006.123638.

References
1.
MAREN T . Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev. 1967; 47(4):595-781. DOI: 10.1152/physrev.1967.47.4.595. View

2.
Khalifah R . The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem. 1971; 246(8):2561-73. View

3.
Crandall E, KLOCKE R, Forster R . Hydroxyl ion movements across the human erythrocyte membrane. Measurement of rapid pH changes in red cell suspensions. J Gen Physiol. 1971; 57(6):664-83. PMC: 2203127. DOI: 10.1085/jgp.57.6.664. View

4.
Osborne W, TASHIAN R . An improved method for the purification of carbonic anhydrase isozymes by affinity chromatography. Anal Biochem. 1975; 64(1):297-303. DOI: 10.1016/0003-2697(75)90434-0. View

5.
Steiner H, Jonsson B, Lindskog S . The catalytic mechanism of carbonic anhydrase. Hydrogen-isotope effects on the kinetic parameters of the human C isoenzyme. Eur J Biochem. 1975; 59(1):253-9. DOI: 10.1111/j.1432-1033.1975.tb02449.x. View